Patients and rate of adverse event by diagnosis
| Diagnosis | Total patients | Patients with AE (%) | Total infusions | Infusions followed up with AE (%) |
|---|---|---|---|---|
| AE, adverse event; CVID, common variable immunodeficiency. | ||||
| Immunodeficiency | ||||
| CVID | 21 | 15 (71.4) | 178 | 48 (27.0) |
| X-linked agammaglobulinaemia | 5 | 0 (0) | 14 | 0 (0) |
| Other | 7 | 3 (42.9) | 51 | 12 (23.5) |
| Immunomodulation | 25 | 8 (32.0) | 102 | 24 (23.5) |
| Overall | 58 | 26 (44.8) | 345 | 84 (23.5) |